M. Rau

发表

N-terminal B-type natriuretic peptide predicts extent of coronary artery disease and ischemia in patients with stable angina pectoris.

C. Hamm, Michael A Weber, V. Mitrović, 2004, American heart journal.

Rapid effect of single-dose rosiglitazone treatment on endothelial function in healthy men with normal glucose tolerance: data from a randomised, placebo-controlled, double-blind study

W. Koenig, V. Hombach, N. Marx, 2010, Diabetes & vascular disease research.

Empagliflozin does not change cardiac index nor systemic vascular resistance but rapidly improves left ventricular filling pressure in patients with type 2 diabetes: a randomized controlled study

M. Böhm, N. Marx, A. Keszei, 2021, Cardiovascular Diabetology.

Effects of empagliflozin on lipoprotein subfractions in patients with type 2 diabetes: data from a randomized, placebo-controlled study.

W. März, H. Scharnagl, N. Marx, 2021, Atherosclerosis.

Transcatheter closure of atrial septal defect and patent foramen ovale in adult patients using the Amplatzer occlusion device: no evidence for thrombus deposition with antiplatelet agents.

C. Hamm, T. Neumann, J. Neuzner, 2002, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

Recurrent angina after complete coronary revascularization

C. Hamm, Michael A Weber, H. Möllmann, 2007, Clinical Research in Cardiology.

Release pattern of N–terminal pro B–type natriuretic peptide (NT–proBNP) in acute coronary syndromes

C. Hamm, Michael A Weber, A. Berkowitsch, 2006, Clinical Research in Cardiology.

Acute and long-term results of bifurcation stenting (from the Coroflex Registry).

H. Mühling, R. Schulze, A. Cioppa, 2006, The American journal of cardiology.

Relation of N-terminal pro-B-type natriuretic peptide to severity of valvular aortic stenosis.

C. Hamm, Michael A Weber, V. Mitrović, 2004, The American journal of cardiology.

Empagli ozin Leads to a Rapid and Sustained Improvement of Left Ventricular Filling Pressure in Patients With Type 2 Diabetes: a Randomized Controlled Study

M. Rau, 2020 .

The gut hormone glucose-dependent insulinotropic polypeptide is downregulated in response to myocardial injury

N. Marx, M. Lehrke, A. Foldenauer, 2022, Cardiovascular Diabetology.

Effects of empagliflozin on erythropoiesis in patients with type 2 diabetes: Data from a randomized, placebo‐controlled study

J. Jankowski, N. Marx, M. Böhm, 2021, Diabetes, obesity & metabolism.

Empagliflozin reduces markers of acute kidney injury in patients with acute decompensated heart failure

J. Jankowski, J. Floege, N. Marx, 2022, ESC heart failure.

The incretin hormone GIP is upregulated in patients with atherosclerosis and stabilizes plaques in ApoE−/− mice by blocking monocyte/macrophage activation

N. Marx, M. Rückbeil, M. Lehrke, 2018, Molecular metabolism.

Argatroban for elective percutaneous coronary intervention: the ARG-E04 multi-center study.

A. Zeiher, L. Rössig, G. Heyndrickx, 2011, International journal of cardiology.

[Cardiopulmonary exercise capacity increases after interventional ASD-closure].

C. Hamm, T. Neumann, T. Dill, 2004, Zeitschrift fur Kardiologie.

Diagnostic utility of new immunoassays for the cardiac markers cTnI, myoglobin and CK-MB mass.

Dragic Bankovic, Matthias Rau, C. Hamm, 2005, Clinical biochemistry.

Directional Coronary Atherectomy of In-stent Restenosis: A Two-Center Experience

H. Tillmanns, W. Haberbosch, B. Waldecker, 2000 .

Association of the Platelet Glycoprotein IIIa PIA1/A2 Gene Polymorphism to Coronary Artery Disease but not to Nonfatal Myocardial Infarction in Low Risk Patients

J. Stricker, A. Gardemann, H. Tillmanns, 1998, Thrombosis and Haemostasis.

Relation of N-terminal pro B-type natriuretic peptide to progression of aortic valve disease.

C. Hamm, Michael A Weber, V. Mitrović, 2005, European heart journal.

Magnetic resonance to assess the aortic valve area in aortic stenosis: how does it compare to current diagnostic standards?

C. Hamm, T. Dill, R. Brandt, 2003, Journal of the American College of Cardiology.

Peptide YY (PYY) Is Associated with Cardiovascular Risk in Patients with Acute Myocardial Infarction

N. Marx, H. Katus, E. Giannitsis, 2020, Journal of clinical medicine.

Accelerated vascular repair following percutaneous coronary intervention by capture of endothelial progenitor cells promotes regression of neointimal growth at long term follow-up: final results of the Healing II trial using an endothelial progenitor cell capturing stent (Genous R stent).

P. Serruys, S. Silber, R. D. de Winter, 2007, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Circulating endothelial progenitor cells predict angiographic and intravascular ultrasound outcome following percutaneous coronary interventions in the HEALING-II trial: evaluation of an endothelial progenitor cell capturing stent.

P. Serruys, S. Silber, R. D. de Winter, 2007, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Empagliflozin does not change cardiac index nor systemic vascular resistance but rapidly improves left ventricular filling pressure in patients with type 2 diabetes: a randomized controlled study

M. Böhm, N. Marx, A. Keszei, 2020 .

Human and mouse non‐targeted metabolomics identify 1,5‐anhydroglucitol as SGLT2‐dependent glycemic marker

R. Stoehr, J. Adamski, N. Marx, 2021, Clinical and translational medicine.

Transcatheter closure of a ruptured ventricular septum after myocardial infarction using a venous approach

C. Hamm, H. Möllmann, T. Dill, 2005, Zeitschrift für Kardiologie.